A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-kappa B nexus

Shukla, Sudhanshu and Patric, Irene Rosita Pia and Thinagararjan, Sivaarumugam and Srinivasan, Sujaya and Mondal, Baisakhi and Hegde, Alangar S and Chandramouli, Bangalore A and Santosh, Vani and Arivazhagan, Arimappamagan and Somasundaram, Kumaravel (2013) A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-kappa B nexus. In: Cancer Research, 73 (23). pp. 6563-6573.

PDF Can_Rese_73-23_ 6563_2013.pdf - Published Version Restricted to Registered users only Download (1MB) | Request a copy

Abstract

Glioblastoma (GBM) is the most common, malignant adult primary tumor with dismal patient survival, yet the molecular determinants of patient survival are poorly characterized. Global methylation profile of GBM samples (our cohort; n = 44) using high-resolution methylation microarrays was carried out. Cox regression analysis identified a 9-gene methylation signature that predicted survival in GBM patients. A risk-score derived from methylation signature predicted survival in univariate analysis in our and The Cancer Genome Atlas (TCGA) cohort. Multivariate analysis identified methylation risk score as an independent survival predictor in TCGA cohort. Methylation risk score stratified the patients into low-risk and high-risk groups with significant survival difference. Network analysis revealed an activated NF-kappa B pathway association with high-risk group. NF-kappa B inhibition reversed glioma chemoresistance, and RNA interference studies identified interleukin-6 and intercellular adhesion molecule-1 as key NF-kappa B targets in imparting chemoresistance. Promoter hypermethylation of neuronal pentraxin II (NPTX2), a risky methylated gene, was confirmed by bisulfite sequencing in GBMs. GBMs and glioma cell lines had low levels of NPTX2 transcripts, which could be reversed upon methylation inhibitor treatment. NPTX2 overexpression induced apoptosis, inhibited proliferation and anchorage-independent growth, and rendered glioma cells chemosensitive. Furthermore, NPTX2 repressed NF-kappa B activity by inhibiting AKT through a p53-PTEN-dependent pathway, thus explaining the hypermethylation and downregulation of NPTX2 in NF-kappa B-activated high-risk GBMs. Taken together, a 9-gene methylation signature was identified as an independent GBM prognosticator and could be used for GBM risk stratification. Prosurvival NF-kappa B pathway activation characterized high-risk patients with poor prognosis, indicating it to be a therapeutic target. (C) 2013 AACR.

Item Type:	Journal Article
Publication:	Cancer Research
Publisher:	American Association for Cancer Research
Additional Information:	Copyright of this article belongs to American Association for Cancer Research.
Department/Centre:	Division of Biological Sciences > Microbiology & Cell Biology
Date Deposited:	30 Dec 2013 12:34
Last Modified:	30 Dec 2013 12:34
URI:	http://eprints.iisc.ac.in/id/eprint/48063

Actions (login required)

View Item